Todos Medical Provides Corporate Update: Retooling to Focus on Long COVID Epidemic
NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, ISRAEL, Sept. 26, 2023 (GLOBE NEWSWIRE) — via NewMediaWire…
NEW YORK, NY, ALPHARETTA, GA and TEL AVIV, ISRAEL, Sept. 26, 2023 (GLOBE NEWSWIRE) — via NewMediaWire…
Vancouver, British Columbia–(ACN Newswire – September 26, 2023) – Doubleview Gold Corp. (TSXV: DBG) (OTCQB:…
VANCOUVER, BC / ACN Newswire / September 26, 2023 / Rover Metals Corp. (TSXV:ROVR)(OTCQB:ROVMF)(FSE:4XO) (“Rover”…
NEW YORK–(BUSINESS WIRE)–#KBRA–On September 21, 2023, KBRA assigned an A+ rating with a Stable Outlook…
Research from Cambridge Mobile Telematics shows a 2.86% reduction in phone motion distraction in Missouri…
WALTHAM, Mass.–(BUSINESS WIRE)–Wolters Kluwer Health has appointed Rafael Sidi as Senior Vice President & General…
Joint implementation with Acra solidifies Tavant’s presence within the Non-QM space and will progress with…
Technology is making significant advancements in any and every industry and healthcare turns out to…
Symantec combines global threat intelligence with Google Cloud’s gen AI expertise to simplify threat analysis…
Symantec combines global threat intelligence with Google Cloud’s gen AI expertise to simplify threat analysis…
Focused on the Unique Security Needs of Healthcare: It Ensures Seamless and Protected Access for…
Deconvolution Analysis Shows 60% Increase in GH Secretion, Comparable to Established Values in Normal Children…
Deconvolution Analysis Shows 60% Increase in GH Secretion, Comparable to Established Values in Normal Children…
INPEFA® (sotagliflozin) recently approved by FDA for treatment of heart failure LX9211 is an investigational,…
INPEFA® (sotagliflozin) recently approved by FDA for treatment of heart failure LX9211 is an investigational,…
AUSTIN, Texas, Sept. 26, 2023 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) Announces that Hutrukin is…
AUSTIN, Texas, Sept. 26, 2023 (GLOBE NEWSWIRE) — XBiotech Inc. (NASDAQ: XBIT) Announces that Hutrukin is…
Synfini Unites Neuro-Symbolic AI, Robotic Automation, and World-class Chemistry Data to Dramatically Accelerate Drug Discovery; Company Leverages More Than $40 Million in Non-dilutive…
Synfini Unites Neuro-Symbolic AI, Robotic Automation, and World-class Chemistry Data to Dramatically Accelerate Drug Discovery; Company Leverages More Than $40 Million in Non-dilutive…
Reata acquisition bolsters Biogen’s rare disease portfolio with the addition of SKYCLARYS® (omaveloxolone), the first…